Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer (Alliance A031201 Trial)
- Citation:
- J Clin Oncol vol 41 (18) 3352-62
- Year:
- 2023
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- Yes
- Book Volume:
- 12
- Parents:
- 3071
- Children:
- None
- Pharmas:
- Astellas
- Grants:
- U10CA180821, U10CA180882, UG1CA233180, UG1CA233253, UG1CA233290, UG1CA233323, UG1CA233339, P30 CA008748, U10CA180888, UG1CA180830 (SWOG); P30 CA047904, R50 CA211241;UG1 CA233184, U10 CA180863
- Corr. Author:
- Authors:
- Michael J. Morris Glenn Heller David W. Hillman Olivia Bobek Charles Ryan Emmanuel S. Antonarakis Alan H. Bryce Olwen Hahn Himisha Beltran Andrew J. Armstrong Lawrence Schwartz Lionel D. Lewis Jan H. Beumer Brooke Langevin Eric C. McGary Paul T. Mehan Amir Goldkorn Bruce J. Roth Han Xiao Colleen Watt Mary-Ellen Taplin Susan Halabi Eric J. Small
- Networks:
- CA011, CA136, HEARTLAND, KAISER, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC010, LAPS-NH012, LAPS-NY016, LAPS-PA015, MN022
- Study
- Alliance-A031201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: